马基莓提取物 | 奥力搾油化株式会社

产品名称: 马基莓提取物
发明名称: 美白材料
专利号: 6144536
申请日: 2013/5/14
授权日: 2017/5/19
摘要: 本发明的目的在于提供新的美白剂，其抑制由内皮素及α-MSH诱发的黑色素细胞中黑素的产生，并且抑制在黑色素细胞中生成的黑色素沉积在角质形成细胞中。【解决方案】用于解决上述课题的本发明中的特征如下：（1）由内皮素和α-MSH诱导的黑色素细胞中的黑素生成抑制剂，其以马基莓提取物为有效成分；（2）以马基莓提取物为有效成分的角质形成细胞的黑色素沉着抑制剂；（3）以马基莓提取物为有效成分的美白剂。

产品名称: 马基莓提取物
发明名称: 干眼症预防和治疗剂
专利号: 6265500
申请日: 2013/12/17
授权日: 2018/1/5
摘要: 本发明中的干眼症预防·治疗剂是抑制泪液分泌能力降低、进而抑制泪腺组织中活性氧生成的新成分，本发明中的干眼症预防·治疗剂含有马基莓提取物作为有效成分。此外，本发明中的干眼症预防·治疗剂含有从马基莓中提取的飞燕草素（Delphinidin）糖苷作为有效成分。此外，本发明中的干眼症预防和治疗剂还含有Delphinidin-3-山楂苷-5-葡萄糖苷、Delphinidin-3，5-diglucoside、Delphinidin-3-sambubioside和Delphinidin-3-glucoside中至少，优选Delphinidin-3，含有5-diglucoside作为有效成分。

产品名称: 马基莓提取物
发明名称: PROPHYLACTIC/THERAPEUTIC AGENT FOR DRY EYE
专利号: CA2895353
申请日: 2013/12/17
授权日: 2019/10/1
摘要: Provided is a prophylactic/therapeutic agent for dry eye, which comprises a novel component capable of preventing the deterioration of a tear fluid secretion ability and also capable of inhibiting the generation of active oxygen in tear gland tissues. The prophylactic/therapeutic agent for dry eye according to the present invention contains a maqui berry extract as an active ingredient. The prophylactic/therapeutic agent for dry eye according to the present invention may contain, as an active ingredient, a delphinidin glycoside that is extracted from maqui berry. The prophylactic/therapeutic agent for dry eye according to the present invention may contain at least one component selected from delphinidin-3-sambubioside-5-glucoside, delphinidin-3,5-diglucoside, delphinidin-3-sambubioside and delphinidin-3-glucoside, desirably delphinidin-3,6-diglucoside, as an active ingredient.

产品名称: 马基莓提取物
发明名称: 干眼症预防和治疗剂
专利号: 10-2070479
申请日: 2013/12/17
授权日: 2020/1/20
摘要: 本发明提供一种可抑制泪液分泌能力降低、并可抑制泪腺组织中活性氧生成的新成分的本发明中所述的儿童眼干预防和治疗剂，本发明中的儿童眼干预防和治疗剂中含有麦克贝里提取物作为有效成分。此外，本发明中的干儿防治剂含有从马基莓（MaquiBerry）中提取的飞燕草素（Delphinidin）糖苷作为有效成分。此外，本发明中的儿童干眼防治剂中还可以含有飞燕草素-3-生物苷-5-葡萄糖苷、飞燕草素-3，含有选自5-花翠素苷、飞燕草素-3-生物糖苷和飞燕草素-3-葡糖苷中的至少一种，优选含有飞燕草素-3，5-花翠素苷作为有效成分。

产品名称: 马基莓提取物
发明名称: PROPHYLACTIC/THERAPEUTIC AGENT FOR DRY EYE
专利号: US11033566
申请日: 2013/12/17
授权日: 2021/6/15
摘要: Provided is a prophylactic/therapeutic agent for dry eye, which comprises a novel component capable of preventing the deterioration of a tear fluid secretion ability and also capable of inhibiting the generation of active oxygen in tear gland tissues. The prophylactic/therapeutic agent for dry eye according to the present invention contains a maqui berry extract as an active ingredient. The prophylactic/therapeutic agent for dry eye according to the present invention may contain, as an active ingredient, a delphinidin glycoside that is extracted from maqui berry. The prophylactic/therapeutic agent for dry eye according to the present invention may contain at least one component selected from delphinidin-3-sambubioside-5-glucoside, delphinidin-3,5-diglucoside, delphinidin-3-sambubioside and delphinidin-3-glucoside, desirably delphinidin-3,5-diglucoside, as an active ingredient.

产品名称: 马基莓提取物
发明名称: PROPHYLACTIC/THERAPEUTIC AGENT FOR DRY EYE
专利号: 239478
申请日: 2013/12/17
授权日: 2019/2/1
摘要: Provided is a prophylactic/therapeutic agent for dry eye, which comprises a novel component capable of preventing the deterioration of a tear fluid secretion ability and also capable of inhibiting the generation of active oxygen in tear gland tissues. The prophylactic/therapeutic agent for dry eye according to the present invention contains a maqui berry extract as an active ingredient. The prophylactic/therapeutic agent for dry eye according to the present invention may contain, as an active ingredient, a delphinidin glycoside that is extracted from maqui berry. The prophylactic/therapeutic agent for dry eye according to the present invention may contain at least one component selected from delphinidin-3-sambubioside-5-glucoside, delphinidin-3,5-diglucoside, delphinidin-3-sambubioside and delphinidin-3-glucoside, desirably delphinidin-3,5-diglucoside, as an active ingredient.

研究开发